This two-part review explores the nanoscale in inhalation delivery. The first part covers the
deposition, fate, toxicity and effects of nanoparticles delivered via inhalation. The second …

This article is the second part of a review on the nanoscale in pulmonary drug delivery.
Specifically it summarises and analyses the potential of the different inhalation delivery …

Pulmonary drug delivery has attracted tremendous interest in the past two decades. In order
to get both local and systemic effects, lungs as the main part of the respiratory system offer …

The pulmonary route offers an exceptional, non-invasive administration site for drug
delivery. The principal characteristics that make the lungs an appealing route for drug …

Inhalation therapy is still limited by the low bioavailability of the administered drugs.
Advantages of the pulmonary administration site like large resorption area, low enzymatic …

Respiratory diseases gather a wide range of disorders which are generally difficult to treat,
partly due to a poor delivery of drugs to the lung with adequate dose and minimum side …

The pulmonary route has recently gained momentum as a suitable avenue for drug delivery.
The large alveolar surface area of approximately 75 m2 coupled with the thin epithelial …

The advent of nanotechnology has reignited interest in the lungs as a major route of drug
delivery for both systemic and local treatments. The large surface area of the lungs and the …

The field of nanotechnology may hold the promise of significant improvements in the health
and well being of patients, as well as in manufacturing technologies. The knowledge of this …

We are providing an update to our previously published review paper on inhaled
nanoparticles, thus updating with the most recent reports in the literature. The field of …